Browsing "1. College of Medicine (의과대학)" by Author : 1212

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 40 to 99 of 302

This table browses all dspace content
Issue DateTitleJournal Title
2022Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease GUT AND LIVER
2016Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes YONSEI MEDICAL JOURNAL
2015Chronic HMGCR/HMG-CoA Reductase Inhibitor Treatment Contributes to Dysglycemia by Upregulating Hepatic Gluconeogenesis through Autophagy InductionAUTOPHAGY
2011Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans EUROPEAN JOURNAL OF ENDOCRINOLOGY
2006Clinical and biochemical characteristics of nonobese type 2 diabetic patients with glutamic acid decarboxylase antibody in KoreaMETABOLISM-CLINICAL AND EXPERIMENTAL
2023Clinical Effects of a Home Care Pilot Program for Patients with Type 1 Diabetes Mellitus: A Retrospective Cohort Study DIABETES & METABOLISM JOURNAL
2018Clinical efficacy of the novel thiazolidinedione lobeglitazone in patients with type 2 diabetesDIABETES & METABOLISM
2017Clinical parameters affecting dapagliflozin response in patients with type 2 diabetesDIABETES & METABOLISM
2020Cohort Profile: Firefighter Research on the Enhancement of Safety and Health (FRESH), a Prospective Cohort Study on Korean Firefighters YONSEI MEDICAL JOURNAL
2018Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus FRONTIERS IN ENDOCRINOLOGY
2020Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate nameMETABOLISM-CLINICAL AND EXPERIMENTAL
2015Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practiceDIABETES & METABOLISM
2016Comparison and Validation of 10 Equations Including a Novel Method for Estimation of LDL-cholesterol in a 168,212 Asian Population MEDICINE
2017Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes. Endocrinology and Metabolism (대한내분비학회지)
2006Comparison of Body Fat Composition and Serum Adiponectin Levels in Diabetic Obesity and Non-diabetic ObesityOBESITY
2022Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study DIABETES & METABOLISM JOURNAL
2019Comparison of hepatocellular carcinoma risk between patients treated with glimepiride and gliclazideDiabetes & Metabolism
2020Comparison of Renal Effects of Ezetimibe-Statin Combination Versus Statin Monotherapy: A Propensity-Score-Matched Analysis JOURNAL OF CLINICAL MEDICINE
2018Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis Endocrinology and Metabolism (대한내분비학회지)
2020Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitisMETABOLISM-CLINICAL AND EXPERIMENTAL
2019Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea Endocrinology and Metabolism (대한내분비학회지)
2022DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice DIABETES & METABOLISM JOURNAL
2006Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes EUROPEAN JOURNAL OF ENDOCRINOLOGY
2016Depot-Specific Changes in Fat Metabolism with Aging in a Type 2 Diabetic Animal Model PLOS ONE
2007Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal modelMETABOLISM-CLINICAL AND EXPERIMENTAL
2007Design, synthesis, and discovery of stilbene derivatives based on lithospermic acid B as potent protein tyrosine phosphatase 1B inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS
2017Diabetes self-assessment score and the development of diabetes A 10-year prospective study MEDICINE
2010Dietary monounsaturated fatty acids but not saturated fatty acids preserve the insulin signaling pathway via IRS-1/PI3K in rat skeletal muscleLIPIDS
2011Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model. DIABETES & METABOLISM JOURNAL
2018Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study SCIENTIFIC REPORTS
2020Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in Vitro and in Vivo JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS
2019Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis DIABETES THERAPY
2012Dimethyl sulfoxide reduces hepatocellular lipid accumulation through autophagy induction AUTOPHAGY
2020Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression SCIENTIFIC REPORTS
2013Discovery of DiPeptidyl Peptidase-4 Gene Variants and the Associations with Efficacy of Vildagliptin in Patients with Type 2 Diabetes - A Pilot Study JOURNAL OF DIABETES & METABOLISM
2006Does birthweight predict adolescent adiponectin levels?CLINICAL ENDOCRINOLOGY
2008Echogenic carotid artery plaques are associated with vertebral fractures in postmenopausal women with low bone mass.CALCIFIED TISSUE INTERNATIONAL
2016Economic Burden of Hypoglycemia in Patients with Type 2 Diabetes Mellitus from Korea PLOS ONE
2009Effect of ABCA1 variant on atherogenic dyslipidaemia in patients with Type 2 diabetes treated with rosiglitazoneDIABETIC MEDICINE
2014Effect of cilostazol on carotid intima-media thickness in type 2 diabetic patients without caridiovascular eventENDOCRINE
2020Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubulesDIABETES OBESITY & METABOLISM
2020Effect of Ezetimibe on Glucose Metabolism and Inflammatory Markers in Adipose Tissue BIOMEDICINES
2017Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control studyINTERNATIONAL JOURNAL OF CANCER
2020Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes Mellitus DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY
2016Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study Endocrinology and Metabolism (대한내분비학회지)
2006Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic controlCLINICAL ENDOCRINOLOGY
2011Effects of leptin and adiponectin on pancreatic β-cell functionMETABOLISM-CLINICAL AND EXPERIMENTAL
2006Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitusMETABOLISM-CLINICAL AND EXPERIMENTAL
2018Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db miceINTERNATIONAL JOURNAL OF OBESITY
2016Effects of Omega-3 Fatty Acid Supplementation on Diabetic Nephropathy Progression in Patients with Diabetes and Hypertriglyceridemia. PLOS ONE
2010Effects of pioglitazone on subclinical atherosclerosis and insulin resistance in nondiabetic renal allograft recipients. NEPHROLOGY DIALYSIS TRANSPLANTATION
2005Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetesCLINICAL PHARMACOLOGY & THERAPEUTICS
2007Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitusCLINICAL ENDOCRINOLOGY
2018Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer Endocrinology and Metabolism (대한내분비학회지)
2023Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study DIABETES & METABOLISM
2020Efficacy and Safety of Gemigliptin as Add-On Therapy to Insulin, With or Without Metformin, in Patients With Type 2 Diabetes Mellitus (ZEUS II Study)DIABETES OBESITY & METABOLISM
2019Efficacy and Safety of Gemigliptin in Post-Transplant Patients With Type 2 Diabetes MellitusTRANSPLANTATION PROCEEDINGS
2020Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin-naïve people with type 2 diabetes: The EDITION AP randomized controlled trialDIABETES OBESITY & METABOLISM
2016Efficacy of different dipeptidyl peptidase-4 (DPP-4) inhibitors on metabolic parameters in patients with type 2 diabetes undergoing dialysis MEDICINE
2018Elevated N-acetyl-beta-D-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional studyJOURNAL OF DIABETES AND ITS COMPLICATIONS

Browse

Links